Legislation

Title: Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement
Sponsored by: Delegates Beitzel and McComas
Status: In the House - Hearing 3/03 at 1:30 p.m.
Analysis: Fiscal and Policy Note

Synopsis

Requiring a prescriber to notify the Prescription Drug Monitoring Program as to whether the prescriber has received education regarding the risks of opioid use, is aware that an opioid overdose reversal drug is available, and has prescribed or dispensed an opioid overdose reversal drug if the prescriber prescribes or dispenses an opioid in a dosage of 50 morphine milligram equivalents or more; and prohibiting a prescriber from being required to make the notification more than once for each patient.

Committees

Original:: Health and Government Operations Click to view Recorded Media

Committee Testimony

Witness List

Details

Introduced in a prior session as: HB1125 Session: 2021 Regular Session

Bill File Type: Regular

Effective Date(s): October 1, 2022

History

Legislation History
Chamber House Calendar Date 2/11/2022 Legislative Date 2/11/2022 Action First Reading Health and Government Operations Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement Proceedings
Chamber House Calendar Date 2/14/2022 Legislative Date 2/14/2022 Action Hearing 3/03 at 1:30 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	2/11/2022	2/11/2022	First Reading Health and Government Operations
			Text - First - Prescription Drug Monitoring Program - Prescribers of Opioids - Notification Requirement
House	2/14/2022	2/14/2022	Hearing 3/03 at 1:30 p.m.

File Code

Subjects

Statutes